NCT04318496

Brief Summary

Introduction: Chest blunt trauma accounts in up to 65% of polytrauma patients. In patients with 0-2 rib fracture, the treatment is relatively limited to oral pain killer and breathing exercise. The patients will suffer two weeks of severe pain accompanied with poor sleep and inability to preform simple daily live activities. In this double blind randomized control study, the investigators offer acupuncture as an additional treatment option. Methods: The study is a double blind randomized control trial. the study will include the press needle acupuncture (Acu) and placebo (Con) group. Both groups will receive one treatment, following the first visit to the clinic after chest trauma accident.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 20, 2020

Completed
3 days until next milestone

Study Start

First participant enrolled

March 23, 2020

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 24, 2020

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2021

Completed
Last Updated

November 17, 2021

Status Verified

November 1, 2021

Enrollment Period

1.3 years

First QC Date

March 20, 2020

Last Update Submit

November 15, 2021

Conditions

Keywords

Blunt chest traumaAcupuncturePress tack needleRib fracture

Outcome Measures

Primary Outcomes (2)

  • Numerical Rating Scale (NRS) - rest

    pain scale form 1-10 when 10 is the most painful

    3 months

  • Numerical Rating Scale (NRS) - mobile

    pain scale form 1-10 when 10 is the most painful

    3 months

Secondary Outcomes (6)

  • Visual Analogue Pain Scale (VAS)

    4 days

  • Face Rating Scale (FRS)

    4 days

  • Flow meter

    4 days

  • Verran and Snyder-Halpern sleep scale

    4 days

  • Chest plain film

    4 days

  • +1 more secondary outcomes

Study Arms (2)

Acupuncture with press tack needle group (Acu)

EXPERIMENTAL

the press tack needles (PYONEX Φ0.20×0.6 mm made by Seirin Corporation) has a diameter of 0.2 mm and length of 0.6 mm will be used on the following bilateral points; GB 36 (Waiqiu), GB 34 (YangLingQuan), ST 36 (Zusanli), LI 4 (HeGu), LU 7 (LieQue), TH 5 (Waiguan) press tack needles retention time will be 4 days.

Other: Press Tack Acupuncture

Placebo group (Con)

PLACEBO COMPARATOR

The pess tack placebo is PYONEX sticker and pack that is identical to the press needle, except that the needle part was removed. The acupuncturist will apply the stickers on the following bilateral acupoints: GB 36 (Waiqiu), GB 34 (YangLingQuan), ST 36 (Zusanli), LI 4 (HeGu), LU 7 (LieQue), TH 5 (Waiguan) press tack stickers retention time will be 4 days.

Other: Press Tack Placebo

Interventions

PYONEX Φ0.20×0.6 mm made by Seirin Corporation

Also known as: Press Tack Needle/ sticker needle/ PYONEX
Acupuncture with press tack needle group (Acu)

PYONEX placebo sticker made by Seirin Corporation

Also known as: PYONEX placebo
Placebo group (Con)

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 20-80 year-old
  • Patients have chest trauma described by themselves or medical chart record within one week
  • Injury Severity Score (ISS) is less than 18 points
  • Body Mass Index(BMI)\<30

You may not qualify if:

  • Sternal fracture
  • Injury Severity Score (ISS) is equal or more than 18 points
  • History of intercostal nerve injury
  • History of cardiovascular disease
  • History of chronic lung disease
  • Significant lung mass or chest deformity noted in the chest plain film

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Out-Patient Clinic of China Medical University Hospital

Taichung, 404472, Taiwan

Location

Related Publications (2)

  • Kao PY, Lottering B, Lu TY, Ho WC, Lin YS, Huang TM, Chen CK, Chen JX, Lee YC, Chen FP, Ben-Arie E. Press tack needle stimulation for blunt chest trauma: a randomized double-blind control trial. Interact Cardiovasc Thorac Surg. 2022 Jun 15;35(1):ivac158. doi: 10.1093/icvts/ivac158.

  • Kao PY, Ben-Arie E, Lu TY, Ho WC, Lee YC, Lin YS, Chen CK, Chen JX, Huang TM, Chen FP. Acupuncture for blunt chest trauma: A protocol for a double-blind randomized control trial. Medicine (Baltimore). 2021 May 7;100(18):e25667. doi: 10.1097/MD.0000000000025667.

MeSH Terms

Conditions

Thoracic InjuriesRib Fractures

Condition Hierarchy (Ancestors)

Wounds and InjuriesFractures, Bone

Study Officials

  • Peiyu Kao, M.D.

    China Medical University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Study nurse 1 will be responsible to randomize and prepare the needles in the envelopes. Outside the envelopes, there will be a number belonged to one patient, and inside the envelopes, there will 14 separate sterile needle which can be either placebo or true press tack needles. The envelopes and the pouches of needle will look the same. The acupuncturist will be asked not to check the needles when they insert them. At the time of acupuncture, a nurse will accompany the acupuncturist and will verify that he is not examining the needles closely. Study nurse 2 will do the measurement. The acupuncturist, patients and study nurse 2 will be blinded.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Double Blinded Randomized Control Trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 20, 2020

First Posted

March 24, 2020

Study Start

March 23, 2020

Primary Completion

June 30, 2021

Study Completion

June 30, 2021

Last Updated

November 17, 2021

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will not share

Locations